Search results
Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do...
Simply Wall St. via Yahoo Finance· 12 hours agoProtagonist Therapeutics (NASDAQ:PTGX) has had a great run on the share market with its stock up by...
StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Sell
ETF DAILY NEWS· 3 days agoProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was downgraded by investment analysts at...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Average Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 23 hours agoShares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have received an average rating of “Moderate Buy” from the five research firms that ...
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average of...
ETF DAILY NEWS· 17 hours agoShares of Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a ...
Sarepta Therapeutics (NASDAQ:SRPT) Trading 4.1% Higher
ETF DAILY NEWS· 22 hours agoSarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report)’s share price traded up 4.1% during trading on Friday . Several analysts recently weighed in ...
Relay Therapeutics executive sells over $540k in company stock By Investing.com
Investing.com· 4 days agoRelay Therapeutics, Inc. (NASDAQ:RLAY) executive Peter Rahmer, the company's Chief Corporate...
It Looks Like Intellia Therapeutics, Inc.'s (NASDAQ:NTLA) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 4 days ago(NASDAQ:NTLA) recently. Shareholders will be interested in what the board will have to say about...
Halozyme Therapeutics (NASDAQ:HALO) Updates FY24 Earnings Guidance
ETF DAILY NEWS· 19 hours agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance ...
Akero Therapeutics (NASDAQ:AKRO) Stock Price Up 5.8%
ETF DAILY NEWS· 22 hours agoShares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) shot up 5.8% during mid-day trading on Friday . 196,306 shares were traded during mid-day ...
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives $32.00 Consensus Price Target from Brokerages
ETF DAILY NEWS· 1 day agoShares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned a consensus rating of “Buy” from the seven analysts that are currently ...